Back to articles
Comparative guide · 6 min read

CoQ10 vs PQQ — does the trendy mitochondrial supplement actually work?

Updated 2026-05-09 · Reviewed by SupplementScore editors · No sponsorships

Both are sold as "mitochondrial support" — and on a chemistry slide both fit that description. But the evidence base behind them is in different leagues. CoQ10 is a Tier 2 supplement with four decades of clinical research, including positive trials in heart failure and statin-induced myopathy. PQQ is a Tier 3 trending compound with mostly preclinical data and a small number of underpowered human trials. The marketing implies parity. The evidence does not.

Quick verdict

GoalBetter choiceWhy
Statin-related muscle complaints CoQ10 Statins block CoQ10 synthesis; supplementation directly replaces what the drug depletes. Multiple RCTs at 100–200 mg/day support symptomatic improvement.
Heart failure as adjunct therapy CoQ10 The Q-SYMBIO trial (300 mg/day, 2 years) showed a significant reduction in major adverse cardiovascular events in HFrEF.
Migraine prevention CoQ10 AAN evidence-graded; 100 mg three times daily used in positive trials.
"Mitochondrial biogenesis" / longevity claims Neither (yet) PQQ has the more impressive preclinical biogenesis data, but human translation is unproven. CoQ10 doesn't claim biogenesis at all.
Lowest evidence-cost ratio CoQ10 $0.30–0.50/day for 100–200 mg ubiquinone. PQQ runs $1–2/day at clinically tested doses.

How they compare on the things that matter

Mechanism — they do different things

CoQ10 (coenzyme Q10, ubiquinone in its oxidised form) is a lipid-soluble electron carrier embedded in the inner mitochondrial membrane. It physically shuttles electrons between Complex I/II and Complex III of the electron transport chain — meaning your cells literally cannot make ATP without it. Endogenous synthesis declines with age, and statins block a shared pathway with cholesterol synthesis (the mevalonate pathway), which is why statin users frequently end up with depressed CoQ10 levels.

PQQ (pyrroloquinoline quinone) is a redox cofactor and a potent antioxidant. Its most-cited mechanistic claim is "mitochondrial biogenesis" — promoting the formation of new mitochondria via PGC-1α signalling. This is well-documented in cell culture and rodent studies. The translation to humans at supplemental doses (10–40 mg/day) is much less established. PQQ is not part of the human electron transport chain in the way CoQ10 is.

Evidence base by clinical endpoint

Practical rule. If you have a clinical condition that CoQ10 has trial evidence for — statin myopathy, heart failure, migraines — buy CoQ10. PQQ is currently a "watching brief" supplement: interesting mechanism, real but small human signals, not enough trial weight to justify the price for general use.

Dose and form

For CoQ10, ubiquinone (the cheaper, oxidised form) is what most positive trials used. Ubiquinol (the reduced form) is somewhat better-absorbed in adults over 40 — worth the modest premium if you're in that age bracket and using CoQ10 for cardiac or statin-related indications. Effective doses run 100–300 mg/day, taken with a fat-containing meal because both forms are lipid-soluble.

For PQQ, trial doses run 10–40 mg/day, with 20 mg being most common. Not lipid-soluble; can be taken with or without food. The "Enzyme CoQ10 + PQQ stack" combination products on the market are popular, but the PQQ dose in those is often well below the 20 mg level used in the Nakano trial — read the label.

Safety

CoQ10 is among the best-tolerated supplements; the main caution is a theoretical interaction with warfarin (CoQ10 has structural similarity to vitamin K2 and may modestly reduce anticoagulant effect). Tell your prescriber. PQQ has limited long-term human safety data but has been generally well-tolerated in trials at standard doses; no major adverse-event signal has emerged.

What the price difference buys you

CoQ10 ubiquinone runs roughly $15–25 for a 60-day supply at 100 mg/day; ubiquinol at the same dose runs $25–40. PQQ at 20 mg/day runs $30–60 for a 60-day supply. The combination "mitochondrial" stacks frequently charge $60–80/month for sub-therapeutic amounts of both — generally not a good deal.

Who should skip each

CoQ10 is generally appropriate for adults — no significant contraindications other than the warfarin caution. Effects can take 4–12 weeks to develop, so don't bail at 2 weeks. People taking statins for cardiovascular prevention should not stop the statin; CoQ10 is an adjunct, not a substitute.

PQQ is not recommended for pregnancy, lactation, or children due to insufficient safety data. Anyone considering it for a specific clinical indication (rather than general "energy" claims) should know that the evidence at this stage is largely mechanistic — it may turn into something or it may not.

What we'd actually buy

For most adults seeking mitochondrial support — particularly those over 50, on statins, or with diagnosed cardiovascular conditions: CoQ10 ubiquinone 100–200 mg/day with the largest meal. Adults over 40 can reasonably step up to ubiquinol if cost permits.

For those committed to trying PQQ despite the thin clinical evidence: a standalone 20 mg/day product, taken consistently for 8–12 weeks with subjective tracking. Skip the multi-ingredient "mitochondrial complex" formulations.

Sources

Read more: